Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 5/21/14 → 12/31/17 |
Funding
- United BioSource LLC (Prot #BKM120 // Prot #BKM120)
- Novartis Pharmaceuticals Corporation (Prot #BKM120 // Prot #BKM120)
Prot #CBKM120ZUS40: Modular phase 2 study to link targeted therapy to patients with pathway activated tumors: Module 1 - BKM120 for patients with PI3K-activated tumors
- Chae, Young Kwang (PD/PI)
Project: Research project